Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe revision tag on the page was updated to v3.5.4, replacing the previous v3.5.3. This indicates a software/document version update rather than a change to study content.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange Detected- The page now displays a new revision number, v3.5.3, replacing the previous v3.5.2, signaling a deployment update. This update appears to be a maintenance detail rather than a substantive change to study content or user-facing information.SummaryDifference0.0%

- Check49 days agoChange DetectedSite revision updated to version v3.5.2, replacing the previous v3.5.0 entry.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check85 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No visible changes to the study details.SummaryDifference0.0%

- Check114 days agoChange DetectedRevision: v3.4.2 is shown on the page header/footer. The prior government-funding operating-status notice has been removed, with no changes to the study details.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.